Literature DB >> 11757081

Increased retinal endothelial cell monolayer permeability induced by the diabetic milieu: role of advanced non-enzymatic glycation and polyol pathway activation.

G Leto1, F Pricci, L Amadio, C Iacobini, S Cordone, O Diaz-Horta, G Romeo, P Barsotti, C M Rotella, U di Mario, G Pugliese.   

Abstract

BACKGROUND: Increased vascular permeability could be involved in the pathogenesis of diabetic retinopathy. The present study was aimed at assessing whether high glucose concentrations can impair retinal endothelial cell barrier function directly, irrespective of changes in other determinants of permeability, and the role of non-enzymatic glycation and polyol pathway activation in these alterations.
METHODS: Bovine retinal endothelial cells (BREC) were exposed for various periods to high glucose vs iso-osmolar mannitol and normal glucose containing media+/-agents mimicking or inhibiting advanced glycation end product (AGE) formation and polyol pathway activation. Monolayer permeability was assessed by measuring the transendothelial passage of (125)I-labeled proteins.
RESULTS: Permeability increased significantly (up to +70%) in BREC exposed to high glucose, but not to mannitol, for 1-30 days, vs normal glucose control cells. Exposure to AGE-modified bovine serum albumin (BSA) (> or = 90%) and, to a lesser extent, sorbitol (+28%) mimicked the high glucose effect. The AGE formation and nitric oxide synthase (NOS) inhibitor aminoguanidine significantly reduced (by 60%) changes induced by 30-day exposure to high glucose, whereas methylguanidine, which inhibits only NOS activity, did not affect permeability. Aldose reductase or sorbitol dehydrogenase inhibitors decreased (by approximately 40%) the enhanced leakage produced by 1-day, but not 30-day, incubation in high glucose.
CONCLUSIONS: The present results indicate that high glucose is capable of impairing retinal endothelial cell barrier function directly and that non-enzymatic glycation and polyol pathway activation may mediate these changes, with AGEs participating in the long-term alterations and increased flux through the sorbitol pathway in the short-term effect. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11757081     DOI: 10.1002/dmrr.227

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  7 in total

1.  A three-pore model describes transport properties of bovine retinal endothelial cells in normal and elevated glucose.

Authors:  Sandra V Lopez-Quintero; Xin-Ying Ji; David A Antonetti; John M Tarbell
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-28       Impact factor: 4.799

Review 2.  Genetics of Diabetic Retinopathy, a Leading Cause of Irreversible Blindness in the Industrialized World.

Authors:  Ashay D Bhatwadekar; Aumer Shughoury; Ameya Belamkar; Thomas A Ciulla
Journal:  Genes (Basel)       Date:  2021-07-31       Impact factor: 4.141

3.  Early neural and vascular dysfunctions in diabetic rats are largely sequelae of increased sorbitol oxidation.

Authors:  Yasuo Ido; Jens R Nyengaard; Kathy Chang; Ronald G Tilton; Charles Kilo; Banavara L Mylari; Peter J Oates; Joseph R Williamson
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

4.  Glyceraldehyde-3-phosphate dehydrogenase in retinal microvasculature: implications for the development and progression of diabetic retinopathy.

Authors:  Sally Madsen-Bouterse; Ghulam Mohammad; Renu A Kowluru
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-29       Impact factor: 4.799

5.  Tubedown regulation of retinal endothelial permeability signaling pathways.

Authors:  Nhu Ho; Robert L Gendron; Kindra Grozinger; Maria A Whelan; Emily Anne Hicks; Bimal Tennakoon; Danielle Gardiner; William V Good; Hélène Paradis
Journal:  Biol Open       Date:  2015-07-03       Impact factor: 2.422

6.  OSSC1E-K19, a novel phytochemical component of Osteomeles schwerinae, prevents glycated albumin-induced retinal vascular injury in rats.

Authors:  Chan-Sik Kim; Junghyun Kim; Kyuhyung Jo; Yun Mi Lee; Eunjin Sohn; Nam Hee Yoo; Jin Sook Kim
Journal:  Mol Med Rep       Date:  2015-10-01       Impact factor: 2.952

7.  Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes.

Authors:  Paul Canning; Josephine V Glenn; Daniel K Hsu; Fu-Tong Liu; Tom A Gardiner; Alan W Stitt
Journal:  Exp Diabetes Res       Date:  2007
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.